Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 136

1.

Use of Aspirin and NSAIDs to Prevent Colorectal Cancer [Internet].

Rostom A, Dube C, Lewin G.

Rockville (MD): Agency for Healthcare Research and Quality (US); 2007 Mar.

2.

Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.

Chan AT, Giovannucci EL, Meyerhardt JA, Schernhammer ES, Curhan GC, Fuchs CS.

JAMA. 2005 Aug 24;294(8):914-23.

3.

Low-dose aspirin in the primary prevention of cancer: the Women's Health Study: a randomized controlled trial.

Cook NR, Lee IM, Gaziano JM, Gordon D, Ridker PM, Manson JE, Hennekens CH, Buring JE.

JAMA. 2005 Jul 6;294(1):47-55.

PMID:
15998890
5.

Analysis of risk of bleeding complications after different doses of aspirin in 192,036 patients enrolled in 31 randomized controlled trials.

Serebruany VL, Steinhubl SR, Berger PB, Malinin AI, Baggish JS, Bhatt DL, Topol EJ.

Am J Cardiol. 2005 May 15;95(10):1218-22.

PMID:
15877994
6.

Genetic variants in the UGT1A6 enzyme, aspirin use, and the risk of colorectal adenoma.

Chan AT, Tranah GJ, Giovannucci EL, Hunter DJ, Fuchs CS.

J Natl Cancer Inst. 2005 Mar 16;97(6):457-60. Erratum in: J Natl Cancer Inst. 2005 Aug 17;97(16):1227.

PMID:
15770010
7.

PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.

Ulrich CM, Whitton J, Yu JH, Sibert J, Sparks R, Potter JD, Bigler J.

Cancer Epidemiol Biomarkers Prev. 2005 Mar;14(3):616-9. Erratum in: Cancer Epidemiol Biomarkers Prev. 2005 Dec;14(12):3020.

9.

Rofecoxib for rheumatoid arthritis.

Garner SE, Fidan DD, Frankish RR, Judd MG, Towheed TE, Wells G, Tugwell P.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD003685. Review.

PMID:
15674912
10.

The association of calcium and vitamin D with risk of colorectal adenomas.

Hartman TJ, Albert PS, Snyder K, Slattery ML, Caan B, Paskett E, Iber F, Kikendall JW, Marshall J, Shike M, Weissfeld J, Brewer B, Schatzkin A, Lanza E; Polyp Prevention Study Group..

J Nutr. 2005 Feb;135(2):252-9.

11.

Rofecoxib for osteoarthritis.

Garner SE, Fidan DD, Frankish R, Maxwell L.

Cochrane Database Syst Rev. 2005 Jan 25;(1):CD005115. Review.

PMID:
15654705
12.

Arthritis medicines and cardiovascular events--"house of coxibs".

Topol EJ.

JAMA. 2005 Jan 19;293(3):366-8. Epub 2004 Dec 28. No abstract available.

PMID:
15623849
14.

Risk of cardiovascular events and rofecoxib: cumulative meta-analysis.

J√ľni P, Nartey L, Reichenbach S, Sterchi R, Dieppe PA, Egger M.

Lancet. 2004 Dec 4-10;364(9450):2021-9.

PMID:
15582059
15.

Optimal antithrombotic management of anticoagulated patients with a history of myocardial infarction.

Gibbs WJ, Fugate SE, Vesta KS.

Cardiol Rev. 2004 Nov-Dec;12(6):327-33. Review.

PMID:
15476572
16.

The effectiveness of five strategies for the prevention of gastrointestinal toxicity induced by non-steroidal anti-inflammatory drugs: systematic review.

Hooper L, Brown TJ, Elliott R, Payne K, Roberts C, Symmons D.

BMJ. 2004 Oct 23;329(7472):948. Epub 2004 Oct 8. Review.

17.

Failing the public health--rofecoxib, Merck, and the FDA.

Topol EJ.

N Engl J Med. 2004 Oct 21;351(17):1707-9. Epub 2004 Oct 6. No abstract available.

18.

Clopidogrel used in combination with aspirin compared with aspirin alone in the treatment of non-ST-segment-elevation acute coronary syndromes: a systematic review and economic evaluation.

Main C, Palmer S, Griffin S, Jones L, Orton V, Sculpher M, Henderson R, Sudlow C, Hawkins N, Riemsma R.

Health Technol Assess. 2004 Oct;8(40):iii-iv, xv-xvi, 1-141. Review.

19.

Association of fluids from beverages with risk of rectal cancer.

Murtaugh MA, Ma KN, Caan BJ, Slattery ML.

Nutr Cancer. 2004;49(1):25-31.

PMID:
15456632
20.

Supplemental Content

Support Center